Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wang Liu

Showing results (421-430 of 435) with videos related to

Pageof 44
Sort By:
Cancer Research|November 3, 2004
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivoMartin Uhl, Steffen Aulwurm, Jörg Wischhusen, et al.
Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology|May 29, 2015
[The study of the expression and the prognostic value of Survivin and Ki67 in pancreatic endocrine tumors]Wang-wang Liu, Yi Zheng, Zuo-li Xia, et al.
Journal of the American Chemical Society|March 20, 2025
Photo-Switchable Supramolecular Interactions Regulate K<sup>+</sup> Transmembrane Transport and Cancer Cell ApoptosisCong Li, Yaqi Wu, Sheng Bao, et al.
Nature|November 11, 2025
High-performance tandem perovskite LEDs through interlayer photon recyclingYou Ke, Wei Zhu, Chao Ma, et al.
BMC Cardiovascular Disorders|November 27, 2025
Association between waist-to-height ratio and cardiovascular events in patients with chronic obstructive pulmonary disease: the mediating effect of prognostic nutritional indexYuli Cai, Enlin Ye, Wang Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 11, 2006
Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetesSatyanarayana Medicherla, Andrew A Protter, Jing Ying Ma, et al.
Nature|July 26, 2023
Accelerating the energy transition towards photovoltaic and wind in ChinaYijing Wang, Rong Wang, Katsumasa Tanaka, et al.
Acta Pharmacologica Sinica|March 1, 2022
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancersJiang-Yan Cao, Shuang Qi, Hong Wu, et al.
Nature Communications|May 18, 2026
Engineering yeast chromosomal telomeres with a bacteriophage systemWeiqin Deng, Yanyan Li, Yangyang Shao, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 17, 2025
Submicron Structure Confined Polymers for High-Performance Intrinsically Stretchable Light-Emitting DiodesWenkang Shi, Chunyu Hua, Yanyan Cao, et al.
Pageof 44

Showing results (421-430 of 435) with videos related to

Sort By:
Pageof 44
Cancer Research|November 3, 2004
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivoMartin Uhl, Steffen Aulwurm, Jörg Wischhusen, et al.
Zhongguo Ying Yong Sheng Li Xue Za Zhi = Zhongguo Yingyong Shenglixue Zazhi = Chinese Journal of Applied Physiology|May 29, 2015
[The study of the expression and the prognostic value of Survivin and Ki67 in pancreatic endocrine tumors]Wang-wang Liu, Yi Zheng, Zuo-li Xia, et al.
Journal of the American Chemical Society|March 20, 2025
Photo-Switchable Supramolecular Interactions Regulate K<sup>+</sup> Transmembrane Transport and Cancer Cell ApoptosisCong Li, Yaqi Wu, Sheng Bao, et al.
Nature|November 11, 2025
High-performance tandem perovskite LEDs through interlayer photon recyclingYou Ke, Wei Zhu, Chao Ma, et al.
BMC Cardiovascular Disorders|November 27, 2025
Association between waist-to-height ratio and cardiovascular events in patients with chronic obstructive pulmonary disease: the mediating effect of prognostic nutritional indexYuli Cai, Enlin Ye, Wang Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 11, 2006
Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetesSatyanarayana Medicherla, Andrew A Protter, Jing Ying Ma, et al.
Nature|July 26, 2023
Accelerating the energy transition towards photovoltaic and wind in ChinaYijing Wang, Rong Wang, Katsumasa Tanaka, et al.
Acta Pharmacologica Sinica|March 1, 2022
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancersJiang-Yan Cao, Shuang Qi, Hong Wu, et al.
Nature Communications|May 18, 2026
Engineering yeast chromosomal telomeres with a bacteriophage systemWeiqin Deng, Yanyan Li, Yangyang Shao, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 17, 2025
Submicron Structure Confined Polymers for High-Performance Intrinsically Stretchable Light-Emitting DiodesWenkang Shi, Chunyu Hua, Yanyan Cao, et al.
Pageof 44